Member Info for Vertizea-Sun

In effect the US government bought a license for E=MC squared but it took a bit of effort to make it work.

Agree BV but I'll add another point. Something persuaded Christina Coughlin and Shaun Chilton to come on board and that simple fact gives me confidence. Neither of them need the money, or grief, so AS has a compelling story hidden somewhere.

Notrex.....that was tried last summer by running a job ad for a salesman on a quarter of a mill pa. Remember? What happened?

Commerce and if you knew anything about it you wouldn't ask such a stupid question.

Fingers crossed that sometime in January Shaun Chilton begins to answer that question. Prelims are over.

DRS1.....I'm happy for the trial patients....and you?

XNoz......saga

And no mention of CanSEEK except PNT have an interesting pipeline. Read into that what you will. Deafening silence?

I've no experience of pharma but is it different from other industries? Probably not. In which case it's full of jealous has-beens who'd rather die than sign-off on a deal that makes an ex-colleague rich. Especially if he/she declined to employ a member of their family. I've seen it happen.

BTL..."Big splash in ‘the summer’."

Too late matey.

Avacta's board will have discussed next year's funding and will know its source. They don't have the luxury of waiting till the summer. They know and we'll know shortly.

Directors don't have to issue an RNS but equally they are not allowed to trade it.

Exactly BV....webinar on December 12, 2023 from 1 to 2 PM ET

No way

Or even a Fell on stony ground

That'll be The Lonesome Trail.

Thorn....remind us .... a real opinion.

Dr William Tap

"It becomes Standard of Care overnight"

"Although applications should be assessed within 30 days, the average wait hit four months earlier this year following a surge of applications. In an average year, the MHRA normally approves around 750 new trials per year. Since July, it has approved 2,200, wiping out a backlog of almost 1,000."

https://www.telegraph.co.uk/news/2023/11/11/life-saving-drug-trials-go-ahead-faster-uk-brexit/

Why don't you register? It's free, online and probably in English. I'm sure they'll appreciate your contribution to

"Next-generation Cell Therapy: Human Pluripotent Stem Cell-derived Mesenchymal Stromal Cells Genetically Engineered to Express AFFIMER® Proteins to Enhance the Immune Response"

It doesn't add up. It was obvious from the outset the job advert was designed for an individual so why go through the charade? And why isn't it re-advertised?